Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Operations Review
DXCM logo

Dexcom's Q3 Revenue Soars 22% to $1.2 Billion Amid Product Innovation

DXCM10-QFiling Date: 10/30/2025
DexCom, Inc.
Description

What this story covers

Dexcom reported Q3 2025 revenue of $1.209B, up 22%, driven by sensor sales and customer growth. Net income doubled to $284M, supported by investments and Stelo launch. Strong liquidity at $3.3B enables expansions, despite legal and regulatory risks.

Story snapshot

CompanyDexCom, Inc.
TickerDXCM
VariantStandard detailed
Duration10:10
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0001093557-25-000280

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in